glp-1 agonist drug names Market Overview: Agonists and the Obesity Market | Blog The glucagon-like peptide 1 receptor

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has today approved a new indication for Wegovy (semaglutide) to reduce the risk of overweight and obese adults suffering serious heart problems or strokes.

These findings underscore the potential for GLP-1 RAs to offer tailored protection against complex diabetic complications, marking an advancement in personalized medicine for managing diabetes-acute kidney disease.

Engineering new ligands that specifically target multiple G protein-coupled receptors with desired activity profiles requires time-consuming and expensive cycles of design-make-test-analyse work

95% CI: -14.6, -2.6

Once weekly

Drug interactions dont come to the top of my mind when I see GLP-1 agonists in use